S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.33 (-0.06%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.33 (-0.06%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.33 (-0.06%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
S&P 500   3,375.89 (+0.07%)
DOW   27,955.21 (+0.21%)
QQQ   272.33 (-0.06%)
AAPL   459.10 (-0.20%)
MSFT   208.71 (+0.00%)
FB   261.16 (-0.05%)
GOOGL   1,511.33 (-0.35%)
AMZN   3,149.03 (-0.38%)
NVDA   461.02 (+0.72%)
CGC   17.31 (-0.06%)
BABA   253.43 (-0.11%)
TSLA   1,650.45 (+1.82%)
GE   6.67 (+1.06%)
MU   46.01 (-0.28%)
AMD   81.36 (-0.59%)
T   30.04 (+0.43%)
F   7.08 (+0.71%)
ACB   10.87 (+6.78%)
GILD   68.68 (+0.73%)
NFLX   482.35 (+0.21%)
DIS   130.33 (-0.48%)
BAC   26.53 (+0.68%)
BA   178.21 (+1.99%)
Log in

NYSE:OMIOwens & Minor Stock Price, Forecast & News

$16.73
+0.83 (+5.22 %)
(As of 08/14/2020 01:42 PM ET)
Add
Compare
Today's Range
$15.75
Now: $16.73
$16.75
50-Day Range
$7.03
MA: $10.93
$17.01
52-Week Range
$3.63
Now: $16.73
$17.33
Volume30,472 shs
Average Volume2.76 million shs
Market Capitalization$1.07 billion
P/E RatioN/A
Dividend Yield0.06%
Beta0.59
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; various programs to provide logistics and marketing solutions to its suppliers; and contract logistics services to the pharmaceutical, biotechnology, and medical device industries offering a range of supply chain logistics services to manufacturers. In addition, it offers business services comprising order-to-cash, re-labeling, customer service, and returns management; and warehousing and transportation services consisting of storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management, and pick and pack services. The Global Products segment manufactures and sources medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
Read More
Owens & Minor logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 1.8Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.84 out of 5 stars


Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP69073210
Phone804-723-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.21 billion
Cash Flow$3.89 per share
Book Value$7.35 per share

Profitability

Net Income$-62,370,000.00

Miscellaneous

Employees15,400
Market Cap$1.07 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$16.73
+0.83 (+5.22 %)
(As of 08/14/2020 01:42 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OMI News and Ratings via Email

Sign-up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Owens & Minor (NYSE:OMI) Frequently Asked Questions

How has Owens & Minor's stock price been impacted by Coronavirus (COVID-19)?

Owens & Minor's stock was trading at $4.48 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OMI stock has increased by 273.4% and is now trading at $16.73.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Owens & Minor?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Owens & Minor
.

When is Owens & Minor's next earnings date?

Owens & Minor is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Owens & Minor
.

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) issued its earnings results on Tuesday, August, 4th. The company reported $0.20 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.19 by $0.01. The business had revenue of $1.81 billion for the quarter, compared to analysts' expectations of $1.92 billion. Owens & Minor had a positive return on equity of 9.31% and a negative net margin of 1.23%. The company's revenue for the quarter was down 23.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.10 earnings per share.
View Owens & Minor's earnings history
.

How often does Owens & Minor pay dividends? What is the dividend yield for Owens & Minor?

Owens & Minor declared a quarterly dividend on Tuesday, August 4th. Stockholders of record on Tuesday, September 15th will be paid a dividend of $0.002 per share on Wednesday, September 30th. This represents a $0.01 annualized dividend and a dividend yield of 0.05%. The ex-dividend date of this dividend is Monday, September 14th.
View Owens & Minor's dividend history
.

What guidance has Owens & Minor issued on next quarter's earnings?

Owens & Minor updated its FY20 earnings guidance on Tuesday, August, 4th. The company provided EPS guidance of $1.00-1.20 for the period, compared to the Thomson Reuters consensus estimate of $1.06.

What price target have analysts set for OMI?

6 Wall Street analysts have issued 1-year price targets for Owens & Minor's shares. Their forecasts range from $9.50 to $16.00. On average, they anticipate Owens & Minor's share price to reach $12.25 in the next twelve months. This suggests that the stock has a possible downside of 26.8%.
View analysts' price targets for Owens & Minor
.

Has Owens & Minor been receiving favorable news coverage?

Media coverage about OMI stock has trended somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Owens & Minor earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.
View the latest news about Owens & Minor
.

Who are some of Owens & Minor's key competitors?

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include Pfizer (PFE), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Enterprise Products Partners (EPD), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU) and Applied Materials (AMAT).

Who are Owens & Minor's key executives?

Owens & Minor's management team includes the following people:
  • Mr. Charles C. Colpo, Sr. VP of Strategic Relationships (Age 61)
  • Mr. Edward A. Pesicka, Pres, CEO & Director (Age 51)
  • Mr. Robert K. Snead, Exec. VP & CFO (Age 42)
  • Mr. Michael Wayne Lowry, Sr. VP, Corp. Controller & Chief Accounting Officer (Age 57)
  • Mr. Joseph S. Pekala, Sr. VP & Chief Information Officer (Age 48)

What is Owens & Minor's stock symbol?

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Who are Owens & Minor's major shareholders?

Owens & Minor's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.99%), LSV Asset Management (2.84%), Smith Graham & Co. Investment Advisors LP (1.79%), Bank of New York Mellon Corp (1.29%), Prudential Financial Inc. (0.85%) and Principal Financial Group Inc. (0.83%). Company insiders that own Owens & Minor stock include Charles C Colpo, Geoff Taylor Marlatt and Robert J Henkel.
View institutional ownership trends for Owens & Minor
.

Which institutional investors are selling Owens & Minor stock?

OMI stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Vanguard Group Inc., Russell Investments Group Ltd., Prudential Financial Inc., LSV Asset Management, UBS Group AG, Bank of New York Mellon Corp, and New York State Common Retirement Fund.
View insider buying and selling activity for Owens & Minor
.

Which institutional investors are buying Owens & Minor stock?

OMI stock was purchased by a variety of institutional investors in the last quarter, including Grantham Mayo Van Otterloo & Co. LLC, Mackay Shields LLC, Hussman Strategic Advisors Inc., APG Asset Management N.V., Exchange Traded Concepts LLC, Pacer Advisors Inc., Smith Graham & Co. Investment Advisors LP, and Janney Montgomery Scott LLC.
View insider buying and selling activity for Owens & Minor
.

How do I buy shares of Owens & Minor?

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Owens & Minor's stock price today?

One share of OMI stock can currently be purchased for approximately $16.73.

How big of a company is Owens & Minor?

Owens & Minor has a market capitalization of $1.07 billion and generates $9.21 billion in revenue each year. The company earns $-62,370,000.00 in net income (profit) each year or $0.56 on an earnings per share basis. Owens & Minor employs 15,400 workers across the globe.

What is Owens & Minor's official website?

The official website for Owens & Minor is www.owens-minor.com.

How can I contact Owens & Minor?

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.